View the historical price chart for AMRN to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
No, AMRN stock may not be the best buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether AMRN stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
AMRN presents a mixed investment profile for 2025. The company shows strong growth drivers including healthcare sector momentum, though analyst price targets suggest 31.2% downside risk.
Analyst sentiment is mixed with 0 buy ratings vs 0 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 2.06, and consider their own risk tolerance and investment timeline.
Based on our comprehensive analysis of AMRN's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a SELL. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
Based on revenue growth analysis and market trends, amrn stock is projected to reach $20.85 by 2030, representing a 30.5% increase from the current price of $15.98.
Get detailed analyst targets, key factors, and comprehensive forecast analysis
Analyze financial statements and market position
Review price charts and technical indicators
Evaluate market and company-specific risks
Make buy/hold/sell decision with price targets
Healthcare
Drug Manufacturers - General
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and intern...
Get detailed step-by-step analysis, risk assessment, and investment strategies
One Central Plaza, Dublin 2, D02 K7K5
Ireland
Get detailed executive information, governance metrics, and comprehensive corporate data